Next Article in Journal
Unbiased Identification of Proteins Covalently Modified by Complex Mixtures of Peroxidized Lipids Using a Combination of Electrophoretic Mobility Band Shift with Mass Spectrometry
Previous Article in Journal
Physiological Roles of Plant Methionine Sulfoxide Reductases in Redox Homeostasis and Signaling
Previous Article in Special Issue
Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessCase Report
Antioxidants 2018, 7(9), 115; https://doi.org/10.3390/antiox7090115

The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme

1
Integrated Health Options Ltd., Auckland 1050, New Zealand
2
Department of Pathology & Biomedical Science, University of Otago, Christchurch 8140, New Zealand
3
Feedback Research Ltd., Auckland 1050, New Zealand
*
Author to whom correspondence should be addressed.
Received: 6 August 2018 / Revised: 21 August 2018 / Accepted: 28 August 2018 / Published: 30 August 2018
(This article belongs to the Special Issue Vitamin C: Current Concepts in Human Physiology)
Full-Text   |   PDF [198 KB, uploaded 30 August 2018]

Abstract

Glioblastoma multiforme is a high grade malignant brain tumour with a poor prognosis. Here we report the case of a woman with glioblastoma who lived for over four years from diagnosis (median survival 12 months and 2% survival for three years), experiencing good quality of life for most of that time. She underwent initial debulking craniotomy, radiotherapy and chemotherapy, as well as having intravenous vitamin C infusions 2–3 times weekly over the four years from diagnosis. Her progress was monitored by blood tests, regular computerised tomography (CT) and magnetic resonance imaging (MRI) scans, clinical reviews and European Organization for the Research and Treatment of Cancer quality of life questionnaires (EORTC QLQ C30). Our case report highlights the benefits of intravenous vitamin C as a supportive therapy for patients with glioblastoma. View Full-Text
Keywords: vitamin C; intravenous vitamin C; ascorbic acid; glioblastoma; neoplasms; quality of life vitamin C; intravenous vitamin C; ascorbic acid; glioblastoma; neoplasms; quality of life
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Baillie, N.; Carr, A.C.; Peng, S. The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme. Antioxidants 2018, 7, 115.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antioxidants EISSN 2076-3921 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top